mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination.

IF 6.9 1区医学 Q1 IMMUNOLOGY

NPJ Vaccines Pub Date : 2024-10-28 DOI:10.1038/s41541-024-00983-0

Jacqueline K Shaia, Priya Shukla, Lee Jampol, Rishi P Singh

引用次数: 0

Abstract

Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.

查看原文本刊更多论文

mRNA COVID-19 疫苗接种后 21 天和 12 周内与 RVO 的发生无关。

病例报告推测接种 COVID-19 疫苗是否与视网膜血管闭塞 (RVO) 有关。具体来说，以前的文献推测接种后数天至数周内发生视网膜血管闭塞的风险会增加。回顾最近的两项分析后发现，接种 mRNA COVID-19 疫苗似乎不会增加接种后 3 周和 12 周的 RVO 风险。虽然这两项研究的设计不同，但 mRNA 疫苗似乎不会影响 RVO 发生的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NPJ Vaccines Immunology and Microbiology-Immunology

CiteScore

11.90

自引率

4.30%

发文量

146

审稿时长

11 weeks

期刊介绍： Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.